Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?

Affiliations

Comment

Mark R Gilbert et al. Nat Clin Pract Neurol. 2007 Jan.

. 2007 Jan;3(1):14-5.

doi: 10.1038/ncpneuro0375.

¹ Department of Neuro-Oncology, MD Anderson Cancer Center in Houston, TX 77030, USA. mrgilbert@mdanderson.org

No abstract available

Comment on

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.
van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ, Frenay M, Tijssen CC, Grisold W, Sipos L, Haaxma-Reiche H, Kros JM, van Kouwenhoven MC, Vecht CJ, Allgeier A, Lacombe D, Gorlia T. van den Bent MJ, et al. J Clin Oncol. 2006 Jun 20;24(18):2715-22. doi: 10.1200/JCO.2005.04.6078. J Clin Oncol. 2006. PMID: 16782911 Clinical Trial.